- Companies
- 876
- Combined market cap
- $8.2T
- Median PE
- 27.2×
- Median revenue growth
- +8.4%
- Median net margin
- 0.3%
| Company | Market cap | PE | P/S | Revenue growth | Net margin | Dividend yield |
|---|
LLYEli Lilly and, Drug Manufacturers - General | $1.2T | 42.7× | 15.0× | +50% | 33.5% | 0.53% |
|---|
JNJJohnson & Johnson, Drug Manufacturers - Generalcaveat | $635.8B | 40.0× | 6.4× | +8% | n/m | 2.00% |
|---|
ABBVAbbVie, Drug Manufacturers - General | $504.8B | 80.7× | 7.8× | +10% | 9.8% | 2.42% |
|---|
UNHUnitedHealth, Medical - Healthcare Planscaveat | $375.3B | 23.9× | 0.8× | +3% | 3.5% | 2.17% |
|---|
MRKMerck, Drug Manufacturers - General | $358.4B | 116× | 5.4× | +5% | 4.8% | 2.34% |
|---|
TMOThermo Fisher Scientific, Medical - Diagnostics & Researchcaveat | $249.1B | 35.5× | 5.3× | +8% | 14.9% | 0.27% |
|---|
AMGNAmgen, Drug Manufacturers - General | $237.5B | 27.3× | 6.2× | +9% | 23.0% | 2.26% |
|---|
GILDGilead Sciences, Drug Manufacturers - General | $193.5B | n/m | 6.4× | +6% | −10.6% | 2.08% |
|---|
ABTAbbott Laboratories, Medical - Devicescaveat | $179.4B | 38.7× | n/m | n/m | n/m | 2.43% |
|---|
PFEPfizer, Drug Manufacturers - General | $171.2B | 39.5× | 2.7× | −0% | 6.8% | 5.73% |
|---|
DHRDanaher, Medical - Diagnostics & Research | $162B | 40.9× | 6.5× | +5% | 15.9% | 0.66% |
|---|
ISRGIntuitive Surgical, Medical - Instruments & Suppliescaveat | $159.8B | 54.7× | 13.8× | +20% | 25.5% | n/m |
|---|
VRTXVertex Pharmaceuticals, Biotechnology | $132.8B | 30.5× | 10.6× | +10% | 35.0% | n/m |
|---|
BMYBristol-Myers Squibb, Drug Manufacturers - General | $125.6B | 13.5× | 2.6× | +3% | 18.9% | 4.10% |
|---|
MDTMedtronic, Medical - Devices | $122B | 23.4× | 3.3× | +10% | 13.9% | 3.00% |
|---|
CVSCVS Health, Medical - Healthcare Plans | $119.5B | 24.7× | 0.3× | +7% | 1.2% | 2.85% |
|---|
SYKStryker, Medical - Devices | $117.8B | 31.8× | 4.6× | +8% | 14.4% | 1.15% |
|---|
MCKMcKesson, Medical - Distribution | $116.7B | 26.8× | 0.3× | +9% | 1.1% | 0.34% |
|---|
HCAHCA Healthcare, Medical - Care Facilities | $101.5B | 15.7× | 1.3× | +7% | 8.8% | 0.65% |
|---|
ELVElevance Health, Medical - Healthcare Plans | $95.4B | 19.6× | 0.5× | +6% | 2.5% | 1.56% |
|---|
REGNRegeneron Pharmaceuticals, Biotechnology | $82.9B | 19.9× | 5.3× | +9% | 27.9% | 0.46% |
|---|
CICigna, Medical - Healthcare Plans | $81.1B | 12.7× | 0.3× | +8% | 2.3% | 2.02% |
|---|
MRNAModerna, Biotechnology | $79.9B | n/m | 35.9× | −28% | n/m | n/m |
|---|
BSXBoston Scientific, Medical - Devices | $66.2B | 18.5× | 3.2× | +14% | 17.5% | n/m |
|---|
CORCencora, Medical - Distribution | $63.2B | 24.6× | 0.2× | +5% | 0.8% | 0.73% |
|---|
NTRANatera, Medical - Diagnostics & Research | $58.2B | n/m | 21.5× | +38% | −7.1% | n/m |
|---|
CAHCardinal Health, Medical - Distribution | $58B | 34.5× | 0.2× | +14% | 0.7% | 0.82% |
|---|
BDXBecton, Dickinson and, Medical - Instruments & Supplies | $54.2B | 60.1× | 2.6× | +5% | 4.5% | 2.00% |
|---|
EWEdwards Lifesciences, Medical - Devices | $51.3B | 51.2× | 7.9× | +15% | 15.4% | n/m |
|---|
HUMHumana, Medical - Healthcare Plans | $50.7B | 39.9× | 0.3× | +18% | 0.9% | 0.84% |
|---|
AAgilent Technologies, Medical - Diagnostics & Research | $48.8B | 34.0× | 6.6× | +9% | 19.5% | 0.59% |
|---|
IQVIQVIA, Medical - Diagnostics & Research | $46B | 34.7× | 2.7× | +8% | 8.1% | n/m |
|---|
TEVATeva Pharmaceutical Industries, Drug Manufacturers - Specialty & Generic | $45.9B | 65.7× | 2.7× | +4% | 4.1% | n/m |
|---|
MDLNMedline, Medical - Instruments & Suppliescaveat | $44.8B | n/m | n/m | n/m | n/m | n/m |
|---|
WATWaters, Medical - Diagnostics & Research | $44.6B | 113× | 9.6× | +52% | 3.6% | n/m |
|---|
IDXXIDEXX Laboratories, Medical - Diagnostics & Research | $44.1B | 39.4× | 9.7× | +13% | 25.0% | n/m |
|---|
ONCBeOne Medicines, Biotechnology | $42.9B | 67.6× | 7.0× | +34% | 10.7% | n/m |
|---|
ILMNIllumina, Medical - Diagnostics & Research | $40.7B | 50.1× | 9.1× | +5% | 18.4% | n/m |
|---|
RVMDRevolution Medicines, Biotechnology | $40.1B | n/m | n/m | n/m | n/m | n/m |
|---|
BIIBBiogen, Drug Manufacturers - General | $37B | 44.4× | 3.7× | +0% | 8.3% | n/m |
|---|
RPRXRoyalty Pharma, Medical - Pharmaceuticals | $36.7B | 36.3× | 14.5× | +10% | 32.1% | 1.45% |
|---|
RMDResMed, Medical - Instruments & Supplies | $36.5B | 24.2× | 6.5× | +10% | 26.9% | 0.97% |
|---|
CNCCentene, Medical - Healthcare Plans | $34.7B | n/m | 0.2× | +14% | −2.5% | n/m |
|---|
ZTSZoetis, Drug Manufacturers - Specialty & Generic | $33.5B | 13.3× | 3.5× | +1% | 27.5% | 2.58% |
|---|
MTDMettler-Toledo International, Medical - Diagnostics & Research | $33.5B | 37.6× | 8.1× | +7% | 21.9% | n/m |
|---|
GEHCGE HealthCare Technologies, Medical - Devices | $32.3B | 16.4× | 1.5× | +7% | 9.3% | 0.20% |
|---|
ALNYAlnylam Pharmaceuticals, Biotechnology | $30B | 37.8× | 6.2× | +95% | 16.8% | n/m |
|---|
DXCMDexCom, Medical - Devices | $29.4B | 30.9× | 5.9× | +16% | 20.1% | n/m |
|---|
WSTWest Pharmaceutical Services, Medical - Instruments & Supplies | $27.6B | 50.2× | 8.3× | +12% | 17.0% | 0.22% |
|---|
DGXQuest Diagnostics, Medical - Diagnostics & Research | $26.7B | 25.7× | 2.3× | +9% | 9.2% | 1.40% |
|---|
LHLabcorp, Medical - Diagnostics & Research | $26.7B | 27.2× | 1.9× | +6% | 7.0% | 0.88% |
|---|
ROIVRoivant Sciences, Biotechnology | $26.4B | n/m | n/m | −68% | n/m | n/m |
|---|
UTHRUnited Therapeutics, Biotechnology | $25.2B | 21.0× | 8.0× | +2% | 41.6% | n/m |
|---|
INCYIncyte, Biotechnology | $23.5B | 14.7× | 4.0× | +27% | 27.7% | n/m |
|---|
GHGuardant Health, Medical - Diagnostics & Research | $22.7B | n/m | 19.2× | +43% | −38.3% | n/m |
|---|
STESTERIS, Medical - Specialties | $22.6B | 28.4× | 3.7× | +8% | 13.3% | 1.11% |
|---|
THCTenet Healthcare, Medical - Care Facilities | $21.6B | 10.4× | 1.0× | +5% | 10.3% | n/m |
|---|
VTRSViatris, Drug Manufacturers - Specialty & Genericcaveat | $20.7B | n/m | 1.4× | +4% | −2.8% | n/m |
|---|
INSMInsmed, Biotechnology | $20.4B | n/m | 17.9× | +186% | −76.9% | n/m |
|---|
ZBHZimmer Biomet, Medical - Devices | $18.8B | 24.0× | 2.2× | +9% | 9.5% | n/m |
|---|
MEDPMedpace, Medical - Diagnostics & Research | $18.7B | 39.2× | 6.7× | +25% | 17.7% | n/m |
|---|
RVTYRevvity, Medical - Diagnostics & Research | $17.7B | 75.6× | 6.1× | +4% | 8.2% | n/m |
|---|
CRLCharles River Laboratories International, Medical - Diagnostics & Research | $16.5B | n/m | 4.1× | −1% | −6.0% | n/m |
|---|
EXELExelixis, Biotechnology | $16B | 20.3× | 6.6× | +9% | 35.3% | n/m |
|---|
SOLVSolventum, Medical - Instruments & Supplies | $14.5B | 10.4× | 1.7× | −1% | 17.3% | n/m |
|---|
NBIXNeurocrine Biosciences, Biotechnology | $14.5B | 20.9× | 4.3× | +34% | 20.9% | n/m |
|---|
HALOHalozyme Therapeutics, Biotechnology | $14.3B | 37.5× | 8.6× | +41% | 24.9% | n/m |
|---|
JAZZJazz Pharmaceuticals, Drug Manufacturers - General | $13.9B | 14.6× | 3.0× | +13% | 20.4% | n/m |
|---|
BBIOBridgeBio Pharma, Drug Manufacturers - General | $13.4B | n/m | 18.8× | +202% | −97.0% | n/m |
|---|
BAXBaxter International, Medical - Instruments & Supplies | $13.1B | n/m | 1.1× | +5% | −9.3% | n/m |
|---|
PENPenumbra, Medical - Instruments & Supplies | $12.8B | 79.7× | 8.5× | +18% | 10.7% | n/m |
|---|
SMMTSummit Therapeutics, Drug Manufacturers - General | $12.3B | n/m | n/m | n/m | n/m | n/m |
|---|
EHCEncompass Health, Medical - Care Facilities | $12.2B | 20.2× | 2.0× | +9% | 10.0% | n/m |
|---|
BTSGBrightSpring Health Services, Medical - Care Facilities | $11.9B | 36.4× | 0.8× | +26% | 2.5% | n/m |
|---|
DVADavita, Medical - Care Facilities | $11.7B | 15.0× | 0.8× | +6% | 6.0% | n/m |
|---|
AVTRAvantor, Medical - Diagnostics & Research | $11.7B | n/m | 1.8× | −2% | −8.8% | n/m |
|---|
COOCooper Companies, Medical - Instruments & Supplies | $11.6B | 20.9× | 2.7× | +5% | 13.5% | n/m |
|---|
TECHBIO-TECHNE, Biotechnology | $11.4B | 63.1× | 9.4× | −0% | 15.0% | n/m |
|---|
ELANElanco Animal Health, Drug Manufacturers - General | $11.3B | n/m | 2.2× | +12% | −4.0% | n/m |
|---|
UHSUniversal Health Services, Medical - Care Facilities | $11B | 7.6× | 0.6× | +10% | 8.4% | n/m |
|---|
ALGNAlign Technology, Medical - Instruments & Supplies | $11B | 26.9× | 2.7× | +4% | 10.0% | n/m |
|---|
GMEDGlobus Medical, Medical - Instruments & Supplies | $10.9B | 20.8× | 3.5× | +20% | 17.0% | n/m |
|---|
MOHMolina Healthcare, Medical - Healthcare Plans | $10.9B | n/m | 0.2× | +3% | −0.0% | n/m |
|---|
BMRNBiomarin Pharmaceutical, Drug Manufacturers - General | $10.8B | 151× | 3.2× | +11% | 2.1% | n/m |
|---|
GKOSGLAUKOS, Medical - Instruments & Supplies | $10.6B | n/m | 17.2× | +42% | −30.7% | n/m |
|---|
PODDInsulet, Medical - Instruments & Supplies | $10.3B | 27.9× | 3.4× | +29% | 12.3% | n/m |
|---|
ENSGEnsign, Medical - Care Facilities | $10.2B | 27.5× | 1.9× | +19% | 6.9% | n/m |
|---|
MDGLMadrigal Pharmaceuticals, Drug Manufacturers - General | $10B | n/m | 7.8× | +149% | −25.3% | n/m |
|---|
RGENRepligen, Biotechnology | $10B | 242× | 12.7× | +16% | 5.3% | n/m |
|---|
BIOBio-Rad Laboratories, Medical - Diagnostics & Research | $9.9B | 44.8× | 3.8× | +1% | 8.6% | n/m |
|---|
OSCROscar Health, Medical - Healthcare Plans | $9.6B | 22.3× | 0.6× | +43% | 3.6% | n/m |
|---|
HSICHenry Schein, Medical - Distribution | $9.5B | 24.8× | 0.7× | +6% | 3.0% | n/m |
|---|
TXG10x Genomics, Medical - Diagnostics & Research | $9.3B | n/m | 15.1× | −4% | −12.2% | n/m |
|---|
CORTCorcept Therapeutics, Drug Manufacturers - General | $9.3B | 204× | 11.2× | +16% | 6.6% | n/m |
|---|
KRYSKrystal Biotech, Biotechnology | $9.2B | 39.0× | 20.9× | +23% | 54.8% | n/m |
|---|
KYMRKymera Therapeutics, Biotechnology | $9.2B | n/m | 87.7× | +135% | n/m | n/m |
|---|
CAICaris Life Sciences, Medical - Diagnostics & Research | $9B | 86.5× | 9.1× | +85% | 10.6% | n/m |
|---|
PCVXVaxcyte, Biotechnology | $9B | n/m | n/m | n/m | n/m | n/m |
|---|
PTGXProtagonist Therapeutics, Drug Manufacturers - General | $9B | 134× | 31.8× | +35% | 29.4% | n/m |
|---|
BRKRBruker, Medical - Diagnostics & Research | $8.8B | n/m | 2.5× | +2% | −2.0% | n/m |
|---|
TWSTTwist Bioscience, Biotechnology | $8.8B | n/m | 20.3× | +19% | −31.7% | n/m |
|---|
IBRXImmunityBio, Biotechnology | $8.7B | n/m | 52.5× | +193% | n/m | n/m |
|---|
CYTKCytokinetics, Drug Manufacturers - General | $8.5B | n/m | 126× | −21% | n/m | n/m |
|---|
TGTXTG Therapeutics, Drug Manufacturers - General | $8.3B | 19.8× | 10.4× | +76% | 55.2% | n/m |
|---|
ARWRArrowhead Pharmaceuticals, Drug Manufacturers - General | $8.2B | n/m | 12.2× | +17% | −47.8% | n/m |
|---|
SYRESpyre Therapeutics, Drug Manufacturers - General | $8B | n/m | n/m | n/m | n/m | n/m |
|---|
AXSMAxsome Therapeutics, Drug Manufacturers - General | $7.6B | n/m | 9.8× | +57% | −24.7% | n/m |
|---|
PACSPACS, Medical - Care Facilities | $7.5B | 27.2× | 1.4× | +15% | 4.8% | n/m |
|---|
ALKSAlkermes plc., Drug Manufacturers - General | $7.3B | 115× | 4.4× | +11% | 4.0% | n/m |
|---|
IONSIonis Pharmaceuticals, Drug Manufacturers - General | $7.1B | n/m | 8.2× | −7% | −64.7% | n/m |
|---|
PRAXPraxis Precision Medicines, Drug Manufacturers - Generalcaveat | $7.1B | n/m | n/m | n/m | n/m | n/m |
|---|
MSAMSA Safety, Medical - Instruments & Supplies | $7B | 22.7× | 3.6× | +6% | 16.1% | n/m |
|---|
CHEChemed, Medical - Care Facilities | $6.7B | 25.8× | 2.6× | +3% | 10.6% | n/m |
|---|
LNTHLantheus, Medical - Diagnostics & Research | $6.5B | 24.2× | 4.2× | +2% | 17.7% | n/m |
|---|
AMRXAmneal Pharmaceuticals, Drug Manufacturers - General | $6.5B | 41.6× | 2.1× | +9% | 5.0% | n/m |
|---|
HIMSHims & Hers Health, Medical - Care Facilities | $6.5B | n/m | 2.5× | +28% | −5.5% | n/m |
|---|
IOVAIovance Biotherapeutics, Biotechnologycaveat | $6.4B | n/m | 19.6× | +35% | −89.1% | n/m |
|---|
BLCOBausch & Lomb, Medical - Instruments & Supplies | $6.2B | n/m | 1.2× | +9% | −3.2% | n/m |
|---|
RYTMRhythm Pharmaceuticals, Drug Manufacturers - General | $6.1B | n/m | 25.6× | +54% | −85.6% | n/m |
|---|
LGNDLigand Pharmaceuticals, Drug Manufacturers - General | $6.1B | 32.3× | 20.8× | +55% | 67.9% | n/m |
|---|
KNSAKiniksa Pharmaceuticals International, Drug Manufacturers - General | $6B | 79.1× | 7.1× | +59% | 9.6% | n/m |
|---|
GRALGRAIL, Medical - Diagnostics & Research | $5.9B | n/m | 35.8× | +23% | n/m | n/m |
|---|
IMVTImmunovant, Biotechnologycaveat | $5.9B | n/m | n/m | n/m | n/m | n/m |
|---|
MANEVeradermics, Drug Manufacturers - Generalcaveat | $5.8B | n/m | n/m | n/m | n/m | n/m |
|---|
TFXTeleflex, Medical - Instruments & Supplies | $5.8B | n/m | 2.6× | +31% | −45.8% | n/m |
|---|
MMSIMerit Medical Systems, Medical - Instruments & Supplies | $5.6B | 38.6× | 3.5× | +10% | 9.2% | n/m |
|---|
RDNTRadNet, Medical - Diagnostics & Research | $5.5B | n/m | 2.4× | +19% | −0.9% | n/m |
|---|
KODKodiak Sciences, Biotechnology | $5.5B | n/m | n/m | n/m | n/m | n/m |
|---|
CGONCG Oncology, Biotechnology | $5.5B | n/m | n/m | n/m | n/m | n/m |
|---|
COGTCogent Biosciences, Drug Manufacturers - General | $5.4B | n/m | n/m | n/m | n/m | n/m |
|---|
HAEHaemonetics, Medical - Instruments & Supplies | $5.4B | 58.1× | 4.0× | +0% | 7.1% | n/m |
|---|
ORKAOruka Therapeutics, Drug Manufacturers - General | $5.3B | n/m | n/m | n/m | n/m | n/m |
|---|
MIRMMirum Pharmaceuticals, Drug Manufacturers - General | $5.2B | n/m | 8.4× | +44% | n/m | n/m |
|---|
SHCSotera Health, Medical - Care Facilities | $5.2B | 31.8× | 4.2× | +8% | 13.4% | n/m |
|---|
MMEDMiniMed, Medical - Instruments & Suppliescaveat | $5.2B | n/m | n/m | n/m | n/m | n/m |
|---|
BLLNBillionToOne, Medical - Diagnostics & Researchcaveat | $5.1B | 166× | 12.8× | +90% | 9.5% | n/m |
|---|
PTCTPTC Therapeutics, Drug Manufacturers - General | $5.1B | n/m | 5.0× | −43% | −3.8% | n/m |
|---|
SRRKScholar Rock, Biotechnology | $5.1B | n/m | n/m | n/m | n/m | n/m |
|---|
ERASErasca, Drug Manufacturers - General | $5B | n/m | n/m | n/m | n/m | n/m |
|---|
CONConcentra Group Holdings Parent, Medical - Care Facilities | $5B | 25.5× | 2.2× | +14% | 8.7% | n/m |
|---|
LFSTLifeStance Health, Medical - Care Facilities | $4.9B | 99.5× | 3.1× | +20% | 3.2% | n/m |
|---|
HTFLHeartflow, Medical - Instruments & Supplies | $4.9B | n/m | 23.3× | +43% | −55.8% | n/m |
|---|
CRSPCRISPR Therapeutics, Biotechnology | $4.8B | n/m | n/m | −65% | n/m | n/m |
|---|
TVTXTravere Therapeutics, Drug Manufacturers - Generalcaveat | $4.7B | n/m | 8.0× | +77% | −7.4% | n/m |
|---|
OPCHOption Care Health, Medical - Care Facilities | $4.7B | 23.5× | 0.8× | +6% | 3.7% | n/m |
|---|
VNTVontier, Medical - Instruments & Supplies | $4.6B | 14.3× | 1.5× | +1% | 11.3% | n/m |
|---|
LIVNLivaNova, Medical - Devices | $4.5B | 23.9× | 3.0× | +12% | 12.8% | n/m |
|---|
BMIBadger Meter, Medical - Instruments & Supplies | $4.4B | 35.3× | 5.0× | −2% | 14.3% | n/m |
|---|
ITGRInteger, Medical - Devices | $4.3B | 34.6× | 2.3× | +3% | 7.0% | n/m |
|---|
DNTHDianthus Therapeutics, Drug Manufacturers - General | $4.3B | n/m | n/m | −61% | n/m | n/m |
|---|
EWTXEdgewise Therapeutics, Drug Manufacturers - General | $4.3B | n/m | n/m | n/m | n/m | n/m |
|---|
ICUIICU Medical, Medical - Instruments & Supplies | $4.2B | 141× | 1.9× | −9% | 1.4% | n/m |
|---|
ADPTAdaptive Biotechnologies, Biotechnology | $4.1B | n/m | 13.2× | +50% | −20.7% | n/m |
|---|
INDVIndivior Pharmaceuticals, Drug Manufacturers - General | $4.1B | 12.4× | 3.1× | +13% | 26.7% | n/m |
|---|
IRTCiRhythm, Medical - Instruments & Supplies | $4B | n/m | 4.8× | +26% | −1.7% | n/m |
|---|
RLAYRelay Therapeutics, Biotechnologycaveat | $4B | n/m | n/m | +24% | n/m | n/m |
|---|
TNGXTango Therapeutics, Drug Manufacturers - General | $3.9B | n/m | 73.1× | +121% | n/m | n/m |
|---|
ARQTArcutis Biotherapeutics, Drug Manufacturers - General | $3.9B | 142× | 8.5× | +76% | 6.1% | n/m |
|---|
VCYTVeracyte, Medical - Diagnostics & Research | $3.9B | 34.2× | 6.9× | +17% | 20.4% | n/m |
|---|
LQDALiquidia, Drug Manufacturers - General | $3.8B | 30.7× | 8.5× | n/m | 30.7% | n/m |
|---|
NVSTEnvista, Medical - Instruments & Supplies | $3.8B | 40.7× | 1.3× | +12% | 3.3% | n/m |
|---|
PLSEPulse Biosciences, Medical - Instruments & Supplies | $3.8B | n/m | n/m | n/m | n/m | n/m |
|---|
NHCNational Healthcare, Medical - Care Facilities | $3.7B | 26.5× | 2.4× | +7% | 9.0% | n/m |
|---|
ABCLAbCellera Biologics, Drug Manufacturers - General | $3.6B | n/m | 54.8× | +101% | n/m | n/m |
|---|
OGNOrganon, Drug Manufacturers - General | $3.6B | 17.9× | 0.6× | −2% | 3.4% | n/m |
|---|
CDNACareDx, Medical - Diagnostics & Researchcaveat | $3.6B | 33.4× | 7.8× | +34% | 24.2% | n/m |
|---|
XENEXenon Pharmaceuticals, Drug Manufacturers - General | $3.4B | n/m | n/a | −100% | n/a | n/m |
|---|
ACADAcadia Pharmaceuticals, Drug Manufacturers - General | $3.4B | n/m | 3.0× | +12% | 33.4% | n/m |
|---|
IDYAIDEAYA Biosciences, Drug Manufacturers - General | $3.3B | n/m | 14.3× | n/m | −74.8% | n/m |
|---|
WRBYWarby Parker, Medical - Instruments & Supplies | $3.2B | 370× | 3.5× | +11% | 0.8% | n/m |
|---|
CELCCelcuity, Medical - Diagnostics & Research | $3.2B | n/m | n/m | n/m | n/m | n/m |
|---|
ELVNEnliven Therapeutics, Drug Manufacturers - General | $3B | n/m | n/m | n/m | n/m | n/m |
|---|
AMLXAmylyx Pharmaceuticals, Drug Manufacturers - Generalcaveat | $3B | n/m | n/m | n/m | n/m | n/m |
|---|
PBLSParabilis Medicines, Drug Manufacturers - Generalcaveat | $3B | n/m | n/m | n/m | n/m | n/m |
|---|
ATRCAtriCure, Medical - Instruments & Supplies | $3B | 281× | 5.3× | +14% | 1.9% | n/m |
|---|
TARSTarsus Pharmaceuticals, Biotechnology | $3B | n/m | 4.9× | +105% | −7.7% | n/m |
|---|
DNLIDenali Therapeutics, Biotechnologycaveat | $2.9B | n/m | n/m | n/m | n/m | n/m |
|---|
ACHCAcadia Healthcare, Medical - Care Facilities | $2.9B | n/m | 0.9× | +4% | −33.4% | n/m |
|---|
AVAHAveanna Healthcare, Medical - Care Facilities | $2.9B | 10.9× | 1.1× | +20% | 10.6% | n/m |
|---|
DYNDyne Therapeutics, Drug Manufacturers - General | $2.9B | n/m | n/m | n/m | n/m | n/m |
|---|
PRVAPrivia Health, Medical - Care Facilities | $2.9B | 107× | 1.2× | +24% | 1.2% | n/m |
|---|
IRONDisc Medicine, Drug Manufacturers - General | $2.9B | n/m | n/m | n/m | n/m | n/m |
|---|
VKTXViking Therapeutics, Drug Manufacturers - General | $2.8B | n/m | n/a | n/m | n/a | n/m |
|---|
NRIXNurix Therapeutics, Drug Manufacturers - General | $2.8B | 11.0× | 3.9× | n/m | 42.0% | n/m |
|---|
ZLABZai Lab, Drug Manufacturers - General | $2.7B | n/m | 6.0× | +5% | −41.9% | n/m |
|---|
NEOGNeogen, Medical - Diagnostics & Research | $2.7B | n/m | 3.0× | −0% | −6.3% | n/m |
|---|
VRDNViridian Therapeutics, Drug Manufacturers - General | $2.5B | n/m | 35.6× | n/m | n/m | n/m |
|---|
GRDNGuardian Pharmacy Services, Medical - Pharmaceuticalscaveat | $2.5B | 38.3× | 1.7× | +10% | 4.5% | n/m |
|---|
BEAMBeam Therapeutics, Biotechnology | $2.5B | n/m | 15.9× | +159% | −54.7% | n/m |
|---|
TMDXTransMedics, Medical - Devices | $2.5B | 18.4× | 3.7× | +26% | 22.7% | n/m |
|---|
CLOVClover Health Investments, Medical - Healthcare Plans | $2.4B | n/m | 1.0× | +54% | −0.7% | n/m |
|---|
BHCBausch Health Companies, Drug Manufacturers - General | $2.4B | n/m | 0.2× | +10% | −10.1% | n/m |
|---|
BKDBrookdale Senior Living, Medical - Care Facilities | $2.4B | n/m | 0.8× | −4% | −4.5% | n/m |
|---|
ADMAAdma Biologics, Biotechnology | $2.4B | 15.3× | 4.7× | +8% | 33.0% | n/m |
|---|
MDPediatrix Medical, Medical - Care Facilities | $2.4B | 14.0× | 1.2× | +1% | 9.0% | n/m |
|---|
SUPNSupernus Pharmaceuticals, Drug Manufacturers - General | $2.4B | n/m | 2.8× | +25% | −13.2% | n/m |
|---|
RCUSArcus Biosciences, Drug Manufacturers - General | $2.4B | n/m | 20.2× | −55% | n/m | n/m |
|---|
NAMSNewAmsterdam Pharma, Drug Manufacturers - General | $2.4B | n/m | n/m | −89% | n/m | n/m |
|---|
MBXMBX Biosciences, Drug Manufacturers - General | $2.3B | n/m | n/m | n/m | n/m | n/m |
|---|
SLSSELLAS Life Sciences, Drug Manufacturers - General | $2.3B | n/m | n/m | n/m | n/m | n/m |
|---|
CLDXCelldex Therapeutics, Medical - Diagnostics & Research | $2.3B | n/m | n/m | −97% | n/m | n/m |
|---|
UFPTUFP Technologies, Medical - Instruments & Supplies | $2.3B | 31.9× | 3.6× | +7% | 11.4% | n/m |
|---|
ADUSAddus HomeCare, Medical - Care Facilities | $2.3B | 21.4× | 1.5× | +16% | 7.1% | n/m |
|---|
PBHPrestige Consumer Healthcare, Drug Manufacturers - General | $2.3B | 13.4× | 2.0× | −1% | 15.6% | n/m |
|---|
FTREFortrea, Medical - Diagnostics & Researchcaveat | $2.2B | n/m | 0.8× | −2% | −3.2% | n/m |
|---|
AUPHAurinia Pharmaceuticals, Drug Manufacturers - General | $2.2B | n/m | 7.2× | +20% | n/m | n/m |
|---|
PGNYProgyny, Medical - Care Facilities | $2.2B | 31.5× | 1.7× | +6% | 6.0% | n/m |
|---|
PGENPrecigen, Drug Manufacturers - Generalcaveat | $2.2B | n/m | n/m | n/m | n/m | n/m |
|---|
PRGOPERRIGO, Drug Manufacturers - General | $2.2B | n/m | 0.5× | −4% | −41.9% | n/m |
|---|
AGIOAgios Pharmaceuticals, Drug Manufacturers - General | $2.2B | n/m | 22.5× | +141% | n/m | n/m |
|---|
VCELVericel, Biotechnology | $2.2B | 92.5× | 7.1× | +23% | 7.9% | n/m |
|---|
ALMRAlamar Biosciences, Medical - Diagnostics & Researchcaveat | $2.1B | n/m | n/m | n/m | n/m | n/m |
|---|
HRMYHarmony Biosciences, Drug Manufacturers - Generalcaveat | $2.1B | 11.7× | 2.2× | +24% | 18.9% | n/m |
|---|
BHVNBiohaven, Drug Manufacturers - General | $2.1B | n/m | n/m | n/m | n/m | n/m |
|---|
SGRYSurgery Partners, Medical - Care Facilities | $2.1B | n/m | 0.6× | +4% | −2.6% | n/m |
|---|
INSPInspire Medical Systems, Medical - Instruments & Supplies | $2.1B | 15.4× | 2.3× | +4% | 15.0% | n/m |
|---|
AXGNAxogen, Medical - Devices | $2B | n/m | 8.1× | +24% | −13.4% | n/m |
|---|
IMNMImmunome, Drug Manufacturers - General | $2B | n/m | n/a | −100% | n/a | n/m |
|---|
VERAVera Therapeutics, Drug Manufacturers - General | $2B | n/m | n/m | n/m | n/m | n/m |
|---|
ZYMEZymeworks, Drug Manufacturers - General | $2B | n/m | 53.9× | −70% | n/m | n/m |
|---|
RXRXRecursion Pharmaceuticals, Biotechnology | $2B | n/m | 36.1× | −15% | n/m | n/m |
|---|
BCRXBiocryst Pharmaceuticals, Biotechnology | $2B | n/m | 2.1× | +69% | −40.9% | n/m |
|---|
LMATLemaitre Vascular, Medical - Instruments & Supplies | $1.9B | 29.6× | 7.4× | +12% | 25.0% | n/m |
|---|
BRVEBraveheart Bio, Drug Manufacturers - Generalcaveat | $1.9B | n/m | n/m | n/m | n/m | n/m |
|---|
ESTAEstablishment Labs, Medical - Instruments & Supplies | $1.9B | n/m | 7.7× | +39% | −15.8% | n/m |
|---|
MRVIMaravai Lifesciences, Drug Manufacturers - General | $1.9B | n/m | 9.1× | −5% | −37.1% | n/m |
|---|
SEPNSepterna, Drug Manufacturers - General | $1.9B | n/m | 19.1× | n/m | −24.5% | n/m |
|---|
XRAYDENTSPLY SIRONA, Medical - Instruments & Supplies | $1.9B | n/m | 0.5× | −1% | −15.0% | n/m |
|---|
SRPTSarepta Therapeutics, Drug Manufacturers - Generalcaveat | $1.9B | n/m | 0.9× | −20% | −6.9% | n/m |
|---|
XNCRXencor, Drug Manufacturers - General | $1.9B | n/m | 17.8× | −29% | n/m | n/m |
|---|
XERSXeris Biopharma, Drug Manufacturers - General | $1.9B | n/m | 5.5× | +36% | −5.1% | n/m |
|---|
MLYSMineralys Therapeutics, Drug Manufacturers - Generalcaveat | $1.8B | n/m | n/m | n/m | n/m | n/m |
|---|
PVLAPalvella Therapeutics, Drug Manufacturers - General | $1.8B | n/m | n/m | n/m | n/m | n/m |
|---|
BFLYButterfly Network, Medical - Devices | $1.8B | n/m | 16.1× | +28% | −66.7% | n/m |
|---|
TRVITrevi Therapeutics, Drug Manufacturers - General | $1.8B | n/m | n/m | n/m | n/m | n/m |
|---|
VIRVir Biotechnology, Biotechnology | $1.8B | n/m | 5.9× | n/m | −83.0% | n/m |
|---|
SDGRSchrodinger, Drug Manufacturers - General | $1.8B | n/m | 6.9× | +9% | −21.0% | n/m |
|---|
ZBIOZenas BioPharma, Drug Manufacturers - Generalcaveat | $1.8B | n/m | n/m | n/m | n/m | n/m |
|---|
HCSGHealthcare Services, Medical - Care Facilities | $1.7B | 14.7× | 0.9× | +4% | 6.6% | n/m |
|---|
ARDTArdent Health, Medical - Care Facilities | $1.7B | 22.3× | 0.3× | +3% | 1.2% | n/m |
|---|
MAZEMaze Therapeutics, Biotechnologycaveat | $1.7B | n/m | n/m | n/m | n/m | n/m |
|---|
ATECAlphatec, Medical - Instruments & Supplies | $1.7B | n/m | 2.1× | +19% | −13.5% | n/m |
|---|
KMTSKestra Medical Technologies, Medical - Instruments & Supplies | $1.7B | n/m | 16.1× | +61% | n/m | n/m |
|---|
NVCRNovoCure, Medical - Instruments & Supplies | $1.7B | n/m | 2.4× | +11% | −21.2% | n/m |
|---|
PSNLPersonalis, Medical - Diagnostics & Research | $1.7B | n/m | 24.3× | −13% | n/m | n/m |
|---|
URGNUroGen Pharma, Drug Manufacturers - General | $1.7B | n/m | 8.9× | +100% | −51.7% | n/m |
|---|
WGSGeneDx, Medical - Care Facilities | $1.7B | n/m | 3.7× | +25% | −23.4% | n/m |
|---|
ALHCAlignment Healthcare, Medical - Healthcare Plans | $1.7B | 42.4× | 0.4× | +37% | 0.9% | n/m |
|---|
ANIPANI Pharmaceuticals, Drug Manufacturers - General | $1.7B | 15.4× | 1.7× | +31% | 11.1% | n/m |
|---|
KLRAKailera Therapeutics, Drug Manufacturers - Generalcaveat | $1.7B | n/m | n/m | n/m | n/m | n/m |
|---|
The largest 250 of 876.
Rankings of healthcare stocks
Valuation data, not investment advice. Each company's page has its story, charts, financials and peers.